(Q53668293)

17 May 2018

title

Quality of life after the menopause: influence of hormonal replacement therapy. (English)

1 reference

17 May 2018

1 reference

M A Limouzin-Lamothe

1

1 reference

17 May 2018

N Mairon

series ordinal

2

1 reference

17 May 2018

C R Joyce

series ordinal

3

1 reference

17 May 2018

M Le Gal

series ordinal

4

1 reference

17 May 2018

language of work or name

English

0 references

publication date

1 February 1994

1 reference

17 May 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

17 May 2018

volume

170

1 reference

17 May 2018

issue

2

1 reference

17 May 2018

page(s)

618-624

1 reference

17 May 2018

Estrogen therapy during menopause. Practical treatment recommendations

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Hormone replacement therapy: risks and benefits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Estrogen replacement therapy by transdermal estradiol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Treatment of hot flashes with transdermal estradiol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Veralipride: alternative antidopaminergic treatment for menopausal symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Veralipride versus conjugated oestrogens: A double-blind study in the management of menopausal hot flushes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Relationships between psychological symptoms, somatic complaints and menopausal status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

Emotional well-being, sexual behaviour and hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

A scale for the estimation of sleep problems in clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

7 January 2021

Perimenopausal sexuality

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

A longitudinal study of the effects of menopause on sexuality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

A new methodological approach to the evaluation of quality of life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2894%2970239-X

10.1016/S0002-9378(94)70239-X

7 January 2021

Identifiers

DOI

1 reference

17 May 2018

PubMed ID

7509570

1 reference

17 May 2018